Theophylline—A Continuing Enigma

Salter H. On some points in the treatment and clinical history of asthma. Edinburgh Med J 1859;4:1109–1115.

American Medical News. American Medical Association, November 16, 1990.

Rowe DJF , Watson ID , Williams J , Berry DJ . The clinical use and measurement of theophylline. Ann Clin Biochem 1988;25:4–23.

Lam A , Newhouse MT . Management of asthma and chronic airflow limita-tion: Are methylxanthines obsolete? (editorial). Chest 1990;98:44–52.

Newhouse MT . Is theophylline obso-lete? Chest 1990;98:1–3.

Helm SG , Meltzer SM . Improved control of asthma in the office setting: A large-scale study of once-daily evening doses of theophylline. Am J Med 1988;85(Suppl 1B):30–34.

Ullman A , Svedmyr N. Salmeterol, a long acting inhaled B2 adrenoceptor agonist: Comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674–678.

Lofdahl C-G , Svedmyr N. Inhaled formoterol, a new beta2-adrenoceptor agonist, compared to salbutamol in asthmatic patients (abstract). Am Rev Respir Dis 1988;137(4, Part 2):330.

Newhouse MT , Dolovich MB . Con-trol of asthma by aerosols. N Engl J Med 1986;315:870–874.

Jenne JW . Theophylline is no more obsolete than "two puffs qid" of current beta2 agonists (editorial). Chest 1990;98:3–4.

Littenberg B. Aminophylline treat-ment in severe acute asthma—A meta-analysis. JAMA 1988;259:1678–1684.

Siegel D , Sheppard D , Gelb A , Weinberg PF . Aminophylline in-creases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis 1985;132:283–286.

Mountain RD , Neff TA . Oral theo-phylline intoxication: A serious error of patient and physician under-standing. Arch Intern Med 1984;144:724–727.

Goldberg MJ , Park GD , Berlinger WG . Treatment of theophylline intoxication. J Allergy Clin Immunol 1986;78:811–817.

Bertino JS Jr , Walker JW . Reassess-ment of theophylline toxicity: Serum concentrations, clinical course, and treatment. Arch Intern Med 1987;147:757–760.

Paloucek FP , Rodvold KA . Evalua-tion of theophylline overdoses and toxicities. Ann Emerg Med 1988;17:135–144.

Aitken ML , Martin ER . Life-threatening theophylline toxicity is not predicted by serum levels. Chest 1987;91:10–14.

Rall TW . Drugs used in the treatment of asthma. In: Gilman AG , Rall TW , Nies AS , Taylor P , eds. Goodman and Gilman's The pharmacological basis of therapeutics. New York:Pergamon Press, 1990:618–637.

Weinberger M. Pharmacologic management of asthma. J Adolesc Health Care 1987;8:74–83.

Rachelefsky GS , Wo J , Adelson J , et al. Behaviour abnormalities and poor school performance due to oral theophylline use. Pediatrics 1986;78:1133–1138.

Furakawa CT , DuHamel TR , Weimer L , Shapiro GG , Pierson WE , Bierman CW . Cognitive and behav-ioral findings in children taking theophylline. J Allergy Clin Immunol 1988;81:83–88.

Creer TL , McLoughlin JA . The effects of theophylline on cognitive and behavioral performance. J Allergy Clin Immunol 1989;83:1027–1029.

Roberts RJ . Drug therapy in infants: Pharmacologic principles and clinical experience. Philadelphia: WB Saunders Co, 1984.

Aranda JV , Chemtob S , Laudignon N , Sasyniuk BI . Pharmacologic effects of theophylline in the newborn. J Allergy Clin Immunol 1986;78:773–780.

Bakris GL , Sauter ER , Hussey JL , Fisher JW , Guber AO , Winsett R. Effects of theophylline on erythro-poietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med 1990;323:86–90.

Beach RS , Donlon D , Escoto D , McCarthy J , Napolitano A , Sosa R. Theophylline for erythrocytosis after renal transplantation (letter). N Engl J Med 1990;323:1635.

Williams M. Adenosine antagonists. Med Res Rev 1989;9:219–243.

Guyatt GN , Townsend M , Pugsley SO , et al. Bronchodilators in chronic air-flow limitation: Effects on airway function, exercise capacity and quality of life. Am Rev Respir Dis 1987;135:1069–1074.

Aubier M , Roussos C. Effect of theophylline on respiratory muscle function. Chest 1985;88(2, Suppl):91S–97S.

Mahler DA , Matthay RA , Snyder PE , Wells CK , Loke J. Sustained release theophylline reduces dyspnea in non-reversible obstructive airway disease. Am Rev Respir Dis 1985;131:22–25.

Niewoehner DE . Theophylline therapy: A continuing dilemma (editorial). Chest 1990;98:5.

Barnes PJ . A new approach to the treatment of asthma. N Engl J Med 1989;321:1517–1527.

Kraan J , Koeter GH , Van der Mark TW , et al. Dosage and time effects of inhaled budenoside on bronchial hyperreactivity. Am Rev Respir Dis 1988;137:44–48.

Gonzalez JP , Brogden RN . Nedo-cromil sodium: A preliminary review of its pharmacodynamic and pharma-cokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Drugs 1987;34:560–577.

Fanta CH , Rossing TH , McFadden ER Jr . Glucocorticoids in acute asthma: A critical controlled trial. Am J Med 1983;73:845–851.

Ratto D , Alfano C , Sipsey J , Glorsky MM , Sharma O. Are intravenous corticosteroids required in status asthmaticus? JAMA 1988;260:527–529.

Barclay J , Whiting B , Addis GJ . The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease. Eur J Clin Pharmacol 1982;22:388–393.

Guyatt GH , Sackett D , Taylor DW , Chong J , Roberts R , Pugsley SO . Determining optimal therapy: Randomized trials in individual patients. N Engl J Med 1986;314:889–892.